This fund has a 20-year record of success and 7.5% income yield — using options
You may be well aware that during the Federal Reserve’s cycle of interest-rate increases — even banks suffered as the market ...
My Social Security benefit will be $4,500 a month. My wife’s is now $615. Can she get more?
My Social Security chart projects that I will receive about $4,500 a month if I make the same amount in 2024 as I did in 2023 ...
Here are key support levels for the S&P 500 as stocks attempt to bounce back from Wednesday's selloff
Stocks were clinging to small gains after midday Wednesday, pulling back from session highs as bulls looked for a bounce ...
Some Republicans want a bigger child tax credit. Does it have a chance of becoming reality?
As Republicans get ready to deliver a tax package next year, some prominent GOP lawmakers have voiced support for an expanded ...
How this Treasury-market dynamic could lead to the next big leg lower in stocks
Thursday’s selloff in long-dated U.S. government debt was pushing 10- and 30-year yields further into their highest levels in ...
How ageism killed older adults during COVID
In the first days of the COVID-19 pandemic, Margaret Morganroth Gullette immediately became concerned about older adults’ ...
Stock Market Today: Dow up 130 points as Wall Street clings to bounce after Fed-inspired rout
Lennar Corporation shares fell 9% in Thursday’s premarket session after the homebuilder blamed rising mortgage costs for a ...
How a children's book helps explain Wednesday's post-Fed market carnage
If you want an explanation for why Wednesday's shift by the Federal Reserve sent stocks stumbling and bond yields and the ...
Bio-Path More Than Doubles on Preclinical Results of BP1001-A for Obesity
Bio-Path Holdings shares more than doubled as the cancer-focused drug company said preclinical studies of BP1001-A for obesity demonstrated enhanced insulin sensitivity. The stock was recently up 114% ...
Weedmaps founders want to take the company private as cannabis sector runs into headwinds
The founders of Weedmaps want to call it quits on the company’s stock and have offered to take the cannabis store-finder ...
UnitedHealth's stock leads the Dow's losers, a day after being the lone gainer
UnitedHealth's stock was resuming its recent selloff, and was leading the Dow's decliners on an up day, a day after being the lone gainer on a big down day. The stock was shed ...